Health
‘Ambitious’ timeline means DeSantis could pass new vax rules before he leaves office
By Katherine Langford
RFK Jr. eases access to unproven peptides despite opposition from FDA scientists
Katherine Langford
Katherine Langford
Editor-in-Chief · Edina, MN
Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.
More from Katherine →Editor-in-Chief · Thursday, October 29, 2026 at 2:13 PM · 1 min read
The document, primarily written by officials at HHS, faced overwhelming pushback among FDA drug staffers who warned it could undermine the agency’s long-standing mission of keeping unsafe health products off the U.S. market
Up next‘Ambitious’ timeline means DeSantis could pass new vax rules before he leaves officeHealth · 3 min read
